Treato

Company Overview

Snapshot

Founded in January 2008 by Itzchak Lichtenfeld, Treato operates with 1–10 employees. The company raised a total of $20 million across two funding rounds from five investors. In April 2016, Treato was recognized as a Cool Vendor by Gartner.

Business overview

Treato provides a platform that analyzes online conversations about medications and health conditions to help patients and caregivers make informed healthcare decisions. The company identifies, aggregates, and analyzes user-generated content from across the social health web to generate patient voice insights. Its Treato IQ platform offers a consolidated view of patient opinions on brands and therapeutic areas, serving both patients and providers within the digital healthcare sector.

Strategic signal

In August 2018, Treato ceased operations, indicating a significant shift in its market trajectory. This closure suggests challenges in its business model or market adoption, despite earlier recognition as a Gartner Cool Vendor and partnerships with companies like Toluna.

Company Intelligence Q&A

What was a significant partnership for Treato?

In July 2017, Treato partnered with Toluna, a leading healthcare-focused digital platform, to enhance its offerings.

When did Treato appoint a new board member?

In December 2016, Treato appointed healthcare industry veteran Allen Kamer to its Board of Directors.

What recognition did Treato receive from Gartner?

In April 2016, Treato was named a Cool Vendor in Life Sciences by the Gartner Research Group.

When did Treato announce its first annual list of top GERD medications?

In January 2016, Treato announced its first annual list of top gastroesophageal reflux disease (GERD) medications, based on consumer health conversations online.

What was the outcome for Treato in August 2018?

In August 2018, Treato, a startup focused on analyzing online patient discussions, shut down its operations.